These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30957568)
21. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084 [TBL] [Abstract][Full Text] [Related]
22. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842 [TBL] [Abstract][Full Text] [Related]
23. Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study. Akad M; Socolov R; Furnică C; Covali R; Stan CD; Crauciuc E; Pavaleanu I Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744039 [No Abstract] [Full Text] [Related]
24. [Anti-Müllerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome]. Durmanova AK; Otarbaev NK Ter Arkh; 2016; 88(12):41-44. PubMed ID: 28139558 [TBL] [Abstract][Full Text] [Related]
25. Role of kisspeptin in polycystic ovarian syndrome: A metabolomics study. Zhao T; Xiao X; Li L; Tao X; He W; Zhang Q; Wu X; Yuan T Clin Endocrinol (Oxf); 2023 Sep; 99(3):315-325. PubMed ID: 36843187 [TBL] [Abstract][Full Text] [Related]
26. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
27. Kisspeptin levels in relation to sex hormone profile among PCOS patients. Zarei E; Binabaj MM; Zadeh FM; Bakhshandeh Nosrat S; Veghari G; Mansourian A Ir J Med Sci; 2022 Aug; 191(4):1711-1716. PubMed ID: 34378162 [TBL] [Abstract][Full Text] [Related]
28. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters. Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590 [TBL] [Abstract][Full Text] [Related]
29. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573 [TBL] [Abstract][Full Text] [Related]
30. Plasma selenium levels in Turkish women with polycystic ovary syndrome. Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536 [TBL] [Abstract][Full Text] [Related]
31. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of serum Kisspeptin levels among women with Polycystic Ovary Syndrome and normal fertile women. Hassan Ali MA; Mohamad SR J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S97-S100. PubMed ID: 35130228 [TBL] [Abstract][Full Text] [Related]
33. The role of kisspeptin in the pathogenesis of a polycystic ovary syndrome. Aasif A; Alam R; Ahsan H; Khan MM; Khan A; Khan S Endocr Regul; 2023 Jan; 57(1):292-303. PubMed ID: 38127687 [TBL] [Abstract][Full Text] [Related]
34. Insulin resistance in nonobese patients with polycystic ovary syndrome. Toprak S; Yönem A; Cakir B; Güler S; Azal O; Ozata M; Corakçi A Horm Res; 2001; 55(2):65-70. PubMed ID: 11509861 [TBL] [Abstract][Full Text] [Related]
35. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
36. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. Li L; Chen X; He Z; Zhao X; Huang L; Yang D J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573 [TBL] [Abstract][Full Text] [Related]
37. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
38. Serum Kisspeptin levels in unexplained infertility, polycystic ovary syndrome, and male factor infertility. Kaya C; Alay İ; Babayeva G; Gedikbaşı A; Ertaş Kaya S; Ekin M; Yaşar L Gynecol Endocrinol; 2019 Mar; 35(3):228-232. PubMed ID: 30328739 [TBL] [Abstract][Full Text] [Related]
39. Serum X-box-binding protein 1 levels in PCOS patients. Bahçeci E; Kaya C; Karakaş S; Yıldız Ş; Hoşgören M; Ekin M Gynecol Endocrinol; 2021 Oct; 37(10):920-924. PubMed ID: 34160344 [TBL] [Abstract][Full Text] [Related]
40. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]